Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.
Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Bubu OM, Gonzalez M, Figueredo L, Gaggi NL, Plaska CR, Pomara N, Blessing E, Betensky R, Rusinek H, Zetterberg H, Blennow K, Glodzik L, Wisniewski TM, Leon MJ, Osorio RS, Ramos-Cejudo J. Jacobs T, et al. Among authors: berger js. Res Sq [Preprint]. 2024 Mar 14:rs.3.rs-4076789. doi: 10.21203/rs.3.rs-4076789/v1. Res Sq. 2024. PMID: 38559231 Free PMC article. Preprint.
The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.
Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Gonzalez M, Figueredo L, Gaggi NL, Plaska CR, Pomara N, Blessing E, Betensky R, Rusinek H, Zetterberg H, Blennow K, Glodzik L, Wisniweski TM, de Leon MJ, Osorio RS, Ramos-Cejudo J; Alzheimer’s Disease Neuroimaging Initiative. Jacobs T, et al. Among authors: berger js. Immun Ageing. 2024 May 17;21(1):32. doi: 10.1186/s12979-024-00435-2. Immun Ageing. 2024. PMID: 38760856 Free PMC article.
A comparison of computational algorithms for the Bayesian analysis of clinical trials.
Chen Z, Berger JS, Castellucci LA, Farkouh M, Goligher EC, Hade EM, Hunt BJ, Kornblith LZ, Laweler PR, Leifer ES, Lorenzi E, Neal MD, Zarychanski R, Heath A. Chen Z, et al. Among authors: berger js. Clin Trials. 2024 May 16:17407745241247334. doi: 10.1177/17407745241247334. Online ahead of print. Clin Trials. 2024. PMID: 38752434
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Reynolds HR, Cyr DD, Merz CNB, Shaw LJ, Chaitman BR, Boden WE, Alexander KP, Rosenberg YD, Bangalore S, Stone GW, Held C, Spertus J, Goetschalckx K, Bockeria O, Newman JD, Berger JS, Elghamaz A, Lopes RD, Min JK, Berman DS, Picard MH, Kwong RY, Harrington RA, Thomas B, O'Brien SM, Maron DJ, Hochman JS; ISCHEMIA Research Group *. Reynolds HR, et al. Among authors: berger js. J Am Heart Assoc. 2024 Mar 5;13(5):e029850. doi: 10.1161/JAHA.122.029850. Epub 2024 Feb 27. J Am Heart Assoc. 2024. PMID: 38410945 Free PMC article. Clinical Trial.
Coronary Microvascular Dysfunction Is Associated With a Proinflammatory Circulating Transcriptome in Patients With Nonobstructive Coronary Arteries.
Smilowitz NR, Schlamp F, Hausvater A, Joa A, Serrano-Gomez C, Farid A, Hochman JS, Barrett TJ, Reynolds HR, Berger JS. Smilowitz NR, et al. Among authors: berger js. Arterioscler Thromb Vasc Biol. 2024 Apr;44(4):997-999. doi: 10.1161/ATVBAHA.123.320471. Epub 2024 Feb 1. Arterioscler Thromb Vasc Biol. 2024. PMID: 38299358
Burden of cardiometabolic risk factors and vascular health.
Hamo CE, Schlamp F, Drenkova K, Jindal M, Fadzan M, Akinlonu A, Goldberg I, Garshick MS, Berger JS. Hamo CE, et al. Among authors: berger js. Am Heart J. 2024 Mar;269:201-204. doi: 10.1016/j.ahj.2023.11.004. Epub 2024 Jan 5. Am Heart J. 2024. PMID: 38199832
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
Greenstein YY, Hubel K, Froess J, Wisniewski SR, Venugopal V, Lai YH, Berger JS, Chang SY, Colovos C, Shah F, Kornblith LZ, Lawler PR, Gaddh M, Guerrero RM, Nkemdirim W, Lopes RD, Reynolds HR, Amigo JS, Wahid L, Zahra A, Goligher EC, Zarychanski R, Leifer E, Huang DT, Neal MD, Hochman JS, Cushman M, Gong MN. Greenstein YY, et al. Among authors: berger js. Chest. 2024 Apr;165(4):785-799. doi: 10.1016/j.chest.2023.11.019. Epub 2023 Nov 17. Chest. 2024. PMID: 37979717 Clinical Trial.
407 results